Belvarafenib
- Product NameBelvarafenib
- CAS1446113-23-0
- CBNumberCB64806091
- MFC23H16ClFN6OS
- MW478.93
- MDL NumberMFCD31731098
- MOL File1446113-23-0.mol
- MSDS FileSDS
Chemical Properties
| Boiling point | 609.6±55.0 °C(Predicted) |
| Density | 1.562±0.06 g/cm3(Predicted) |
| storage temp. | 2-8°C(protect from light) |
| solubility | DMSO:46.17(Max Conc. mg/mL);96.4(Max Conc. mM) DMSO:PBS (pH 7.2) (1:2):0.33(Max Conc. mg/mL);0.69(Max Conc. mM) DMF:30.0(Max Conc. mg/mL);62.64(Max Conc. mM) |
| form | A crystalline solid |
| pka | 11.16±0.43(Predicted) |
| color | Off-white to yellow |
| InChIKey | KVCQTKNUUQOELD-UHFFFAOYSA-N |
| SMILES | C1=NC(N)=C2SC=C(C(NC3=C(C)C=CC4=C3C=CN=C4NC3=CC=CC(Cl)=C3F)=O)C2=N1 |
| FDA UNII | 31M3WLJ3KG |
| NCI Drug Dictionary | belvarafenib |
Safety
| Symbol(GHS) |
|
|||||||||
| Signal word | Warning | |||||||||
| Hazard statements | H302-H315-H319-H335 | |||||||||
| Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 | |||||||||
| NFPA 704: |
|